| Mepha Pharma AG - Pramipexol-Mepha ER 4.5 mg, Depotabs |
| 65797 | | 05 | | Pramipexol-Mepha ER 4.5 mg | | Depotabs | | N04BC05 | | Pramipexole | | 09.08.2016 | | |
|
| Composition |
| pramipexoli dihydrochloridum monohydricum 4.500 mg corresp. pramipexolum 3.15 mg, hypromellosum, calcii hydrogenophosphas, magnesii stearas, silica colloidalis anhydrica pro compresso. |
| Packungsbestandteile |
| Delayed release tablets | | | | | Active Agent | Dose |
|---|
| Pramipexol Dihydrochloride Monohydrate | 4.5 mg correspond Pramipexol 3.15 mg |
| | BAG: Active Agent | Dose |
|---|
| Pramipexol Dihydrochloride Monohydrate | 4.5 mg |
| | | | Inactive agents |
|---|
| Calcium Hydrogen Phosphate | | Hypromellosum | | Magnesii Stearas | | Silica Colloidalis Anhydrica pro Compresso |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 006 | 30 | 140.34 | 169.05 | B | SL | No |
|
